Form 8-K - Current report:
SEC Accession No. 0001839882-25-013638
Filing Date
2025-03-04
Accepted
2025-03-04 17:28:16
Documents
14
Period of Report
2025-02-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_022725.htm   iXBRL 8-K 26037
2 EMPLOYMENT AGREEMENT, BY AND BETWEEN TONIX PHARMA LIMITED AND SIOBHAN FOGARTY, D ex10-01.htm EX-10.01 283664
  Complete submission text file 0001839882-25-013638.txt   516273

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tnxp-20250227.xsd EX-101.SCH 3024
4 XBRL LABEL FILE tnxp-20250227_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE tnxp-20250227_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_022725_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 25706684
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)